Operating Expenses Summary of Cochlear Limited

Cochlear Limited's latest annual operating expenses in 2024 was 1.17 Billion AUD , up 11.3% from previous year.
Cochlear Limited's latest quarterly operating expenses in 2024 FY was 1.17 Billion AUD , up 11.3% from previous quarter.
Cochlear Limited reported a annual operating expenses of 1.05 Billion AUD in annual operating expenses 2023, up 21.52% from previous year.
Cochlear Limited reported a annual operating expenses of 868.4 Million AUD in annual operating expenses 2022, up 14.99% from previous year.
Cochlear Limited reported a quarterly operating expenses of 615.3 Million AUD for 2024 Q4, down 0.0% from previous quarter.
Cochlear Limited reported a quarterly operating expenses of 559.3 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Cochlear Limited (2024 - 1996)

Historical Annual Operating Expenses of Cochlear Limited (2024 - 1996)

Year	Operating Expenses	Operating Expenses Growth
2024	1.17 Billion AUD	11.3%
2023	1.05 Billion AUD	21.52%
2022	868.4 Million AUD	14.99%
2021	755.2 Million AUD	0.84%
2020	748.9 Million AUD	6.15%
2019	705.49 Million AUD	7.86%
2018	654.1 Million AUD	12.81%
2017	579.8 Million AUD	8.5%
2016	534.35 Million AUD	20.38%
2015	443.9 Million AUD	3.34%
2014	429.55 Million AUD	12.73%
2013	381.05 Million AUD	-16.03%
2012	453.79 Million AUD	30.08%
2011	348.87 Million AUD	8.24%
2010	322.32 Million AUD	-1.4%
2009	326.89 Million AUD	19.92%
2008	272.59 Million AUD	3.75%
2007	262.73 Million AUD	14.35%
2006	229.76 Million AUD	19.76%
2005	191.84 Million AUD	18.23%
2004	162.26 Million AUD	6.84%
2003	151.88 Million AUD	11.84%
2002	135.8 Million AUD	3765.7%
2001	3.51 Million AUD	69.71%
2000	2.07 Million AUD	-24.09%
1999	2.72 Million AUD	-84.93%
1998	18.1 Million AUD	27.62%
1997	14.18 Million AUD	12.88%
1996	12.56 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 FY	1.17 Billion AUD	11.3%
2024 Q4	615.3 Million AUD	0.0%
2024 Q2	559.3 Million AUD	0.0%
2023 Q2	471.5 Million AUD	0.0%
2023 FY	1.05 Billion AUD	21.52%
2023 Q4	583.8 Million AUD	0.0%
2022 Q4	467.9 Million AUD	0.0%
2022 Q2	400.5 Million AUD	0.0%
2022 FY	868.4 Million AUD	14.99%
2021 Q2	352.4 Million AUD	0.0%
2021 FY	755.2 Million AUD	0.84%
2021 Q4	398.9 Million AUD	0.0%
2020 Q2	385.8 Million AUD	0.0%
2020 FY	748.9 Million AUD	6.15%
2020 Q4	363.1 Million AUD	0.0%
2019 Q2	347.29 Million AUD	0.0%
2019 Q4	358.19 Million AUD	0.0%
2019 FY	705.49 Million AUD	7.86%
2018 Q4	341.29 Million AUD	0.0%
2018 FY	654.1 Million AUD	12.81%
2018 Q2	312.79 Million AUD	0.0%
2017 Q4	303.19 Million AUD	0.0%
2017 FY	579.8 Million AUD	8.5%
2017 Q2	276.6 Million AUD	0.0%
2016 FY	534.35 Million AUD	20.38%
2016 Q4	278.51 Million AUD	0.0%
2016 Q2	255.84 Million AUD	0.0%
2015 Q4	233.38 Million AUD	0.0%
2015 Q2	210.51 Million AUD	0.0%
2015 FY	443.9 Million AUD	3.34%
2014 Q2	220.51 Million AUD	0.0%
2014 FY	429.55 Million AUD	12.73%
2014 Q4	209.04 Million AUD	0.0%
2013 Q4	187.23 Million AUD	104.82%
2013 Q3	91.41 Million AUD	0.0%
2013 Q2	91.41 Million AUD	380.3%
2013 Q1	19.03 Million AUD	0.0%
2013 FY	381.05 Million AUD	-16.03%
2012 Q4	- AUD	-100.0%
2012 Q2	19.03 Million AUD	-78.18%
2012 Q1	87.21 Million AUD	0.0%
2012 FY	453.79 Million AUD	30.08%
2012 Q3	19.03 Million AUD	0.0%
2011 Q1	80.58 Million AUD	0.0%
2011 Q2	87.21 Million AUD	8.24%
2011 Q3	87.21 Million AUD	0.0%
2011 Q4	- AUD	-100.0%
2011 FY	348.87 Million AUD	8.24%
2010 FY	322.32 Million AUD	-1.4%
2010 Q4	- AUD	-100.0%
2010 Q3	80.58 Million AUD	0.0%
2010 Q2	80.58 Million AUD	-1.4%
2010 Q1	81.72 Million AUD	0.0%
2009 Q2	81.72 Million AUD	19.92%
2009 FY	326.89 Million AUD	19.92%
2009 Q3	81.72 Million AUD	0.0%
2009 Q1	68.14 Million AUD	0.0%
2009 Q4	- AUD	-100.0%
2008 Q1	143.25 Thousand AUD	0.0%
2008 Q2	68.14 Million AUD	47473.47%
2008 Q4	- AUD	-100.0%
2008 FY	272.59 Million AUD	3.75%
2008 Q3	68.14 Million AUD	0.0%
2007 FY	262.73 Million AUD	14.35%
2007 Q3	143.25 Thousand AUD	0.0%
2007 Q4	- AUD	-100.0%
2007 Q2	143.25 Thousand AUD	-99.73%
2007 Q1	53.42 Million AUD	0.0%
2006 FY	229.76 Million AUD	19.76%
2006 Q4	- AUD	-100.0%
2006 Q3	53.42 Million AUD	0.0%
2006 Q2	53.42 Million AUD	14872.62%
2006 Q1	356.79 Thousand AUD	0.0%
2005 Q1	38.2 Million AUD	0.0%
2005 Q2	356.79 Thousand AUD	-99.07%
2005 Q3	356.79 Thousand AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 FY	191.84 Million AUD	18.23%
2004 Q1	26.25 Thousand AUD	0.0%
2004 FY	162.26 Million AUD	6.84%
2004 Q2	38.2 Million AUD	145436.19%
2004 Q3	38.2 Million AUD	0.0%
2004 Q4	- AUD	-100.0%
2003 FY	151.88 Million AUD	11.84%
2003 Q2	26.25 Thousand AUD	-34.78%
2003 Q1	40.25 Thousand AUD	0.0%
2003 Q3	26.25 Thousand AUD	0.0%
2003 Q4	- AUD	-100.0%
2002 FY	135.8 Million AUD	3765.7%
2002 Q2	40.25 Thousand AUD	-95.42%
2002 Q3	40.25 Thousand AUD	0.0%
2002 Q4	- AUD	-100.0%
2002 Q1	878.25 Thousand AUD	0.0%
2001 Q1	12.98 Million AUD	0.0%
2001 Q3	878.25 Thousand AUD	0.0%
2001 Q4	- AUD	-100.0%
2001 FY	3.51 Million AUD	69.71%
2001 Q2	878.25 Thousand AUD	-93.23%
2000 Q4	- AUD	-100.0%
2000 FY	2.07 Million AUD	-24.09%
2000 Q2	12.98 Million AUD	28.57%
2000 Q1	10.09 Million AUD	0.0%
2000 Q3	12.98 Million AUD	0.0%
1999 Q3	10.09 Million AUD	0.0%
1999 Q2	10.09 Million AUD	28.68%
1999 Q1	7.84 Million AUD	0.0%
1999 FY	2.72 Million AUD	-84.93%
1999 Q4	- AUD	-100.0%
1998 Q4	- AUD	-100.0%
1998 FY	18.1 Million AUD	27.62%
1998 Q1	- AUD	0.0%
1998 Q3	7.84 Million AUD	0.0%
1998 Q2	7.84 Million AUD	0.0%
1997 Q4	- AUD	0.0%
1997 Q1	3.14 Million AUD	0.0%
1997 Q2	- AUD	-100.0%
1997 Q3	- AUD	0.0%
1997 FY	14.18 Million AUD	12.88%
1996 Q3	3.14 Million AUD	0.0%
1996 Q2	3.14 Million AUD	0.0%
1996 Q4	3.14 Million AUD	0.0%
1996 FY	12.56 Million AUD	0.0%

Peer Operating Expenses Comparison of Cochlear Limited

Name	Operating Expenses	Operating Expenses Difference
4DMedical Limited	31.48 Million AUD	-3630.808%
Adherium Limited	267.7 Thousand AUD	-438669.831%
Aroa Biosurgery Limited	66.09 Million AUD	-1677.009%
Atomo Diagnostics Limited	1.6 Million AUD	-73038.095%
Anteris Technologies Ltd	69.14 Million AUD	-1598.63%
Control Bionics Limited	9.82 Million AUD	-11854.099%
CardieX Limited	16.64 Million AUD	-6955.09%
Compumedics Limited	26.88 Million AUD	-4269.792%
CleanSpace Holdings Limited	11.35 Million AUD	-10240.409%
Cyclopharm Limited	13.38 Million AUD	-8678.227%
EMVision Medical Devices Ltd	12.83 Million AUD	-9052.528%
Nova Eye Medical Limited	23.99 Million AUD	-4796.207%
HeraMED Limited	6.78 Million AUD	-17216.931%
Imricor Medical Systems, Inc.	-1.11 Million AUD	105366.082%
ImpediMed Limited	28.04 Million AUD	-4088.866%
InhaleRx Limited	2.59 Million AUD	-45242.02%
LBT Innovations Limited	1.1 Million AUD	-106006.594%
Micro-X Limited	18.76 Million AUD	-6159.859%
Neurotech International Limited	8.75 Million AUD	-13317.411%
OncoSil Medical Limited	12.03 Million AUD	-9655.943%
PolyNovo Limited	34.92 Million AUD	-3263.496%
Respiri Limited	8.03 Million AUD	-14518.8%
SomnoMed Limited	58.97 Million AUD	-1891.774%
Universal Biosensors, Inc.	20 Million AUD	-5772.934%
Uscom Limited	5.52 Million AUD	-21178.816%
Visioneering Technologies, Inc.	9.63 Million AUD	-12092.697%

Global Stocks Search

Cochlear Limited (COH.AX)

Operating Expenses Summary of Cochlear Limited

Annual Operating Expenses Chart of Cochlear Limited (2024 - 1996)

Historical Annual Operating Expenses of Cochlear Limited (2024 - 1996)

Peer Operating Expenses Comparison of Cochlear Limited